Clinical scale expanded adult pluripotent stem cells prevent graft-versus-host disease

Magdalena Kovacsovics-Bankowski, Philip Streeter, Kelsey A. Mauch, Mark R. Frey, Amy Raber, Wouter van t Hof, Robert Deans, Richard Maziarz

Research output: Contribution to journalArticle

45 Citations (Scopus)

Abstract

Adherent bone marrow adult stem cells have been used in the treatment of GVHD. In this study, we investigate the capacity of a newly characterized population of stem cells, the Multipotent Adult Progenitor Cells (MAPC), to modulate acute GVHD. These cells were derived from bone marrow cells and grown extensively without evidence for replicative senescence or loss of differentiating capacity. MAPC significantly decreased mortality of acute GVHD. Moreover, they were non immunogenic and they were not sensitive to NK-lysis. When these cells were added to a mixed lymphocyte reaction (MLR), a dose-dependent suppression of T cell proliferation was observed that was non-MHC restricted, was reversible upon removal of MAPC from culture and was mediated by soluble factors. These data show that in vitro expanded adult stem cells can efficiently control an allo-reactive response associated with acute GVHD, that they are immuno-privileged and present strong immunosuppressive properties.

Original languageEnglish (US)
Pages (from-to)55-60
Number of pages6
JournalCellular Immunology
Volume255
Issue number1-2
DOIs
StatePublished - 2009

Fingerprint

Pluripotent Stem Cells
Adult Stem Cells
Graft vs Host Disease
Stem Cells
Multipotent Stem Cells
Mixed Lymphocyte Culture Test
Cell Aging
Immunosuppressive Agents
Bone Marrow Cells
Cell Culture Techniques
Bone Marrow
Cell Proliferation
T-Lymphocytes
Mortality
Population

Keywords

  • Adult stem cell
  • Bone marrow
  • Cell therapy
  • GVHD
  • Immunosuppression

ASJC Scopus subject areas

  • Immunology

Cite this

Kovacsovics-Bankowski, M., Streeter, P., Mauch, K. A., Frey, M. R., Raber, A., Hof, W. V. T., ... Maziarz, R. (2009). Clinical scale expanded adult pluripotent stem cells prevent graft-versus-host disease. Cellular Immunology, 255(1-2), 55-60. https://doi.org/10.1016/j.cellimm.2008.10.004

Clinical scale expanded adult pluripotent stem cells prevent graft-versus-host disease. / Kovacsovics-Bankowski, Magdalena; Streeter, Philip; Mauch, Kelsey A.; Frey, Mark R.; Raber, Amy; Hof, Wouter van t; Deans, Robert; Maziarz, Richard.

In: Cellular Immunology, Vol. 255, No. 1-2, 2009, p. 55-60.

Research output: Contribution to journalArticle

Kovacsovics-Bankowski, M, Streeter, P, Mauch, KA, Frey, MR, Raber, A, Hof, WVT, Deans, R & Maziarz, R 2009, 'Clinical scale expanded adult pluripotent stem cells prevent graft-versus-host disease', Cellular Immunology, vol. 255, no. 1-2, pp. 55-60. https://doi.org/10.1016/j.cellimm.2008.10.004
Kovacsovics-Bankowski M, Streeter P, Mauch KA, Frey MR, Raber A, Hof WVT et al. Clinical scale expanded adult pluripotent stem cells prevent graft-versus-host disease. Cellular Immunology. 2009;255(1-2):55-60. https://doi.org/10.1016/j.cellimm.2008.10.004
Kovacsovics-Bankowski, Magdalena ; Streeter, Philip ; Mauch, Kelsey A. ; Frey, Mark R. ; Raber, Amy ; Hof, Wouter van t ; Deans, Robert ; Maziarz, Richard. / Clinical scale expanded adult pluripotent stem cells prevent graft-versus-host disease. In: Cellular Immunology. 2009 ; Vol. 255, No. 1-2. pp. 55-60.
@article{b9825e8005684649bbbd279619e5455b,
title = "Clinical scale expanded adult pluripotent stem cells prevent graft-versus-host disease",
abstract = "Adherent bone marrow adult stem cells have been used in the treatment of GVHD. In this study, we investigate the capacity of a newly characterized population of stem cells, the Multipotent Adult Progenitor Cells (MAPC), to modulate acute GVHD. These cells were derived from bone marrow cells and grown extensively without evidence for replicative senescence or loss of differentiating capacity. MAPC significantly decreased mortality of acute GVHD. Moreover, they were non immunogenic and they were not sensitive to NK-lysis. When these cells were added to a mixed lymphocyte reaction (MLR), a dose-dependent suppression of T cell proliferation was observed that was non-MHC restricted, was reversible upon removal of MAPC from culture and was mediated by soluble factors. These data show that in vitro expanded adult stem cells can efficiently control an allo-reactive response associated with acute GVHD, that they are immuno-privileged and present strong immunosuppressive properties.",
keywords = "Adult stem cell, Bone marrow, Cell therapy, GVHD, Immunosuppression",
author = "Magdalena Kovacsovics-Bankowski and Philip Streeter and Mauch, {Kelsey A.} and Frey, {Mark R.} and Amy Raber and Hof, {Wouter van t} and Robert Deans and Richard Maziarz",
year = "2009",
doi = "10.1016/j.cellimm.2008.10.004",
language = "English (US)",
volume = "255",
pages = "55--60",
journal = "Cellular Immunology",
issn = "0008-8749",
publisher = "Academic Press Inc.",
number = "1-2",

}

TY - JOUR

T1 - Clinical scale expanded adult pluripotent stem cells prevent graft-versus-host disease

AU - Kovacsovics-Bankowski, Magdalena

AU - Streeter, Philip

AU - Mauch, Kelsey A.

AU - Frey, Mark R.

AU - Raber, Amy

AU - Hof, Wouter van t

AU - Deans, Robert

AU - Maziarz, Richard

PY - 2009

Y1 - 2009

N2 - Adherent bone marrow adult stem cells have been used in the treatment of GVHD. In this study, we investigate the capacity of a newly characterized population of stem cells, the Multipotent Adult Progenitor Cells (MAPC), to modulate acute GVHD. These cells were derived from bone marrow cells and grown extensively without evidence for replicative senescence or loss of differentiating capacity. MAPC significantly decreased mortality of acute GVHD. Moreover, they were non immunogenic and they were not sensitive to NK-lysis. When these cells were added to a mixed lymphocyte reaction (MLR), a dose-dependent suppression of T cell proliferation was observed that was non-MHC restricted, was reversible upon removal of MAPC from culture and was mediated by soluble factors. These data show that in vitro expanded adult stem cells can efficiently control an allo-reactive response associated with acute GVHD, that they are immuno-privileged and present strong immunosuppressive properties.

AB - Adherent bone marrow adult stem cells have been used in the treatment of GVHD. In this study, we investigate the capacity of a newly characterized population of stem cells, the Multipotent Adult Progenitor Cells (MAPC), to modulate acute GVHD. These cells were derived from bone marrow cells and grown extensively without evidence for replicative senescence or loss of differentiating capacity. MAPC significantly decreased mortality of acute GVHD. Moreover, they were non immunogenic and they were not sensitive to NK-lysis. When these cells were added to a mixed lymphocyte reaction (MLR), a dose-dependent suppression of T cell proliferation was observed that was non-MHC restricted, was reversible upon removal of MAPC from culture and was mediated by soluble factors. These data show that in vitro expanded adult stem cells can efficiently control an allo-reactive response associated with acute GVHD, that they are immuno-privileged and present strong immunosuppressive properties.

KW - Adult stem cell

KW - Bone marrow

KW - Cell therapy

KW - GVHD

KW - Immunosuppression

UR - http://www.scopus.com/inward/record.url?scp=59349085292&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=59349085292&partnerID=8YFLogxK

U2 - 10.1016/j.cellimm.2008.10.004

DO - 10.1016/j.cellimm.2008.10.004

M3 - Article

C2 - 19022422

AN - SCOPUS:59349085292

VL - 255

SP - 55

EP - 60

JO - Cellular Immunology

JF - Cellular Immunology

SN - 0008-8749

IS - 1-2

ER -